IVD Regulation Timing Under Threat From Lack Of Notified Bodies
Executive Summary
The slow designation of notified bodies under the IVD Regulation is likely to mean that the IVD industry will face hurdles due to lack of timely availability of these resources when demand rises exponentially.
You may also be interested in...
MDR Delay: Is It All Good News Or Does It Bring Its Own Problems?
In responding to industry’s plea for more time to comply with the EU’s MDR, the European Commission’s proposed one-year delay may also create some unwelcome repercussions for manufacturers and notified bodies.
MedTech Europe: ‘Pause The EU MDR And IVDR Now!’
For the first time, the EU medtech industry has called on the European institutions to postpone implementation of the Medical Device Regulation and the IVD Regulation until the COVID-19 crisis is over.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.